ACTU

Conviction 12HealthcareScan · Fri, Jun 26, 2026

ACTU$1.76-10.20%

ResistanceSupportVol 14

Vol MA14 197.49K

Mar 27Apr 15May 4May 20Jun 9Jun 26

ACTUATE THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.actuatetherapeutics.com ↗

Price1.76

Change-10.20%

Gap+0.00%

Rel volume1.61×

Avg volume165.44K

Avg $ vol326.77K

SMA 201.96

SMA 502.40

SMA 2004.68

Price vs 50-26.58%

Price vs 200-62.39%

MA stackbearish

50/200 cross—

Supertrenddown · 2.57

RSI (14)33

MACD hist0.01

MACD crossbull · 9d

Stoch %K / %D0 / 12

ADX (14)25

+DI / −DI27 / 17

RSI divergence—

MACD divergence—

ATR %+14.12%

ADR %11.40%

52w high8.72

52w low1.72

From 52w high-79.82%

Above 52w low+2.33%

New 52w highNo

SqueezeOn · 9d

Bollinger width17.13%

%B-0.09

Donchian pos0.00%

Donchian high2.78

Donchian low1.76

AVWAP (52w high)4.14

vs AVWAP high-57.48%

AVWAP (52w low)2.43

vs AVWAP low-27.50%

OBV trendUp

Chaikin MF (20)-0.55

Today vs 20d1.61×

Avg vol (14d)197.49K

Avg vol (20d)165.44K

Avg $ vol (20d)326.77K

Market cap—

RS 3m (vs SPY)-27.31%

RS 6m (vs SPY)-78.32%

RS line new highNo

Trend template0/8

Technical rank4.8

1 week-14.98%

1 month-16.59%

3 months-22.47%

6 months-73.37%

1 year-72.67%

YTD-70.81%

P/E-2.09

P/B12.27

P/S—

P/FCF—

EPS-1.06

Div yield—

ROE-587.36%

ROA-249.43%

Debt/Eq—

Current1.80

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth18.54%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value38.28M

Revenue—

Net income-5.63M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out23.93M

Employees12

ListedTue, Aug 13, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank4.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.11

Support1.81

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACTU

All disclosures →

No recent disclosed trades by Congress in ACTU. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACTU · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Fletcher Aaron G.L. Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Zabrowski Dan Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
RONNEBERG AMY L Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
THOMSON TODD S Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Huber Martin H. Jr. Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Keyes Jason A Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Sawhney Roger Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22

SEC filings

EDGAR filings in ACTU

EDGAR →

No recent SEC filings on file for ACTU.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.